The move follows HHS Office of Inspector General’s revocation of “a favorable advisory opinion issued to the nonprofit that essentially gave it approval to help Medicare patients pay for drug co-payments,” according to the report.
HHS OIG first informed the charity of the revocation in November, following concerns drug companies had unfair influence over the charity. United Therapeutics Corp last month agreed to a $210 million settlement to resolve federal allegations it relied on the charity group to cover Medicare patients’ out-of-pocket drug costs to limit consumers’ price sensitivity and increase sales.
HHS OIG on Friday gave drugmakers permission to provide free drugs to patients in 2018 that previously received financial assistance from Caring Voice Coalition.
“We are grateful to have been able to assist thousands of patients suffering with numerous chronic illnesses and remain committed to fulfilling our charitable mission of improving the lives of patients with chronic illnesses,” Caring Voice Coalition President Greg Smiley said Thursday in a statement cited by Reuters.
The charity has offered financial support to 100,000 people since 2003.
More articles on supply chain:
Celgene to acquire Impact Biomedicines for up to $7B
AdvaMed TV ads call on Congress to end device tax: 4 things to know
FDA OKs expanded use of Amgen’s bone drug: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.